Search

Tulane Ventures has invested $250,000 in Biophoundry, a Tulane University spinout developing engineered phage therapies for antibiotic-resistant infections. Its Phax platform couples computational phage design and selection with rapid phage

Graduates who are nationals or permanent residents of Sub-Saharan African countries can apply for an MPhil in Molecular Cell Biology of Infectious Diseases at the University of Ghana. Scholarships support up to 24 months of study. Applicant

Martha Clokie and Anisha Thanki received £800,000 from BBSRC to advance a bacteriophage product against Salmonella in chickens. le.ac.uk

Applications for Innovate UK Innovation Loans will pause from 11am on October 9, 2026, until January 2027. UK-registered SMEs can submit an expression of interest for loans of £100,000–£5 million for innovative late-stage R&D projects with

Armata Pharmaceuticals has received an additional $3.7 million in non-dilutive funds from the U.S. Department of War to support the Phase 3 programme of AP-SA02, its phage cocktail for complicated Staphylococcus aureus bacteremia. It is the

Professor Yuping Li of the Biozentrum, University of Basel, has received a European Research Council Starting Grant, funded with 1.5 million euros over five years, to study how bacteria detect and defend themselves against jumbophages, gian

Researchers can apply for up to US$50,000 in credits per scientific project. The expanded AI for Science programme accepts any researcher and extends beyond its initial biological-science focus to other fields. Biology and chemistry access

On 12 August 2026 the LEO Foundation announced DKK 61.9 million in Research Grants to 16 international projects, including one to Professor Thomas Sicheritz-Pontén (University of Copenhagen); the foundation's grantee record lists his 2026 R

Inserm's Phage Therapy booster programme, led by its Health technologies and Immunology, inflammation, infectiology and microbiology institutes, will fund a single three-year consortium of 10-12 participants (individual researchers or teams

Dr. Gregory German of Unity Health Toronto will lead P-PEAKS UTI, an international clinical trial in which about 220 women with E. coli urinary tract infections lasting a year or more will receive either personalized phage therapy or placeb

The REPhRAME project, coordinated by Universitätsmedizin Frankfurt under Prof. Maria J.G.T. Vehreschild, has been awarded €15 million through Horizon Europe; it began in June 2026 and is planned to run for five years. It will assess in a ra

Precise Health SA, a Biopôle-based EPFL spin-out, has kicked off an Innosuisse Innovation Project worth approximately CHF 900,000 with the University of Geneva and Geneva University Hospitals (HUG). The project builds on its AI-powered Phag

Gladstone launched the Center for PhAIge Therapy to harness AI for research on drug-resistant infections. NIAID provided an initial $2 million award, with total funding up to $10 million available over the proposed five-year project period.

Intralytix announced a multimillion-dollar NIH P01 award for a Pitt-led CAPT-CEP project developing phage therapy for multidrug-resistant Pseudomonas aeruginosa. The collaboration includes Pitt, Walter Reed, USC, Florida International Unive

NIAID awarded three CAPT-CEP centers to build preclinical tools, assays and models for phage therapy against ESKAPE pathogens. The FY 2026 program provides $6 million across three awards, each up to $1.2 million in annual direct costs for u

PHAGE4DAIR, a Horizon Europe project coordinated by Qeen Biotechnologies (Canada), runs from 1 June 2026 to 31 May 2031 with an EU contribution of €14,869,038.73. It is a multicenter, randomized, double-blind, placebo-controlled, adaptive P

Phage Consultants (Marcin Łoś, Gdynia, Poland) is developing PhageSense, a platform for rapid, sensitive and repeatable detection of bacteriophage infections in bacterial cultures and industrial fermentation samples that combines fluorescen

Argentina, Paraguay, Uruguay and Brazil’s São Paulo and Espírito Santo agencies jointly supported research and knowledge transfer on antimicrobial resistance in intensive food-animal production. Projects could run up to 24 months, with agen

An ODIN-funded collaborative project led by Professor Hanne Ingmer (University of Copenhagen) brings academic and industry partners together to develop next-generation tools for phage-based therapies against chronic wound and urinary tract

Intralytix, Inc. has been awarded a Maryland Manufacturing 4.0 grant to modernize phage manufacturing. It will expand its PhageEngine platform by integrating in silico omics data and building a digital twin to speed process optimization. In